TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence: Systematic Versus Endoscopic-directed Treatment. A Multi-center, Randomized, Clinical Practice Evaluation Study.
Brief Summary: The objective of this study is to evaluate if in the prevention of postoperative recurrence of ileal Crohn's disease immediate initiation of azathioprine postoperatively is superior to delayed (6- 12 mths.) introduction of azathioprine upon disease recurrence assessed by endoscopic criteria. The primary endpoint, disease recurrence, encompasses symptomatic and surgical recurrence as well as severe endoscopic lesions at the final, 2 year, assessment.


Options:
A: Arm Label: Metronidazole + Azathioprine.; Type: EXPERIMENTAL; Interventions: Drug: Metronidazole, Drug: Azathioprine | Arm Label: Metronidazole + Adalimumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole, Drug: Adalimumab | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole + Azathioprine. | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole + Adalimumab | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Metronidazole + Azathioprine. | Intervention Type: DRUG; Name: Adalimumab; Assigned to Arm(s): Metronidazole + Adalimumab
B: Arm Label: Azathioprine; Type: EXPERIMENTAL; Interventions: Drug: Azathioprine, Drug: Mesalazine placebo | Arm Label: Mesalazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine, Drug: Azathioprine placebo | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Azathioprine | Intervention Type: DRUG; Name: Mesalazine; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Azathioprine placebo; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Mesalazine placebo; Assigned to Arm(s): Azathioprine
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: infliximab | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: infliximab; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
D: Arm Label: Systematic azathioprine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine, Procedure: Ileocolonoscopy, Procedure: Small bowel follow trough | Arm Label: Endoscopy-driven azathioprine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine in case of endoscopic recurrence, Procedure: Ileocolonoscopy, Procedure: Small bowel follow trough | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Systematic azathioprine group | Intervention Type: DRUG; Name: Azathioprine in case of endoscopic recurrence; Assigned to Arm(s): Endoscopy-driven azathioprine group | Intervention Type: PROCEDURE; Name: Ileocolonoscopy; Assigned to Arm(s): Endoscopy-driven azathioprine group, Systematic azathioprine group | Intervention Type: PROCEDURE; Name: Small bowel follow trough; Assigned to Arm(s): Endoscopy-driven azathioprine group, Systematic azathioprine group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Brief Summary: This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: oseltamivir + zanamivir | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: oseltamivir + zanamivir's placebo | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: oseltamivir's placebo + zanamivir | Intervention Type: DRUG; Name: oseltamivir + zanamivir; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: oseltamivir + zanamivir's placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: oseltamivir's placebo + zanamivir; Assigned to Arm(s): 3
B: Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Arm Label: Eculizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eculizumab | Intervention Type: DRUG; Name: Eculizumab; Assigned to Arm(s): Eculizumab | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline
C: Arm Label: Lampalizumab Once in Every 4 Weeks (Q4W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Lampalizumab Once in Every 6 Weeks (Q6W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Sham Comparator; Type: SHAM_COMPARATOR; Interventions: Other: Sham | Intervention Type: DRUG; Name: Lampalizumab; Assigned to Arm(s): Lampalizumab Once in Every 4 Weeks (Q4W), Lampalizumab Once in Every 6 Weeks (Q6W) | Intervention Type: OTHER; Name: Sham; Assigned to Arm(s): Sham Comparator
D: Arm Label: Lampalizumab once in every 4 weeks (Q4W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Lampalizumab once in every 6 weeks (Q6W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Sham Comparator; Type: SHAM_COMPARATOR; Interventions: Other: Sham Comparator | Intervention Type: DRUG; Name: Lampalizumab; Assigned to Arm(s): Lampalizumab once in every 4 weeks (Q4W), Lampalizumab once in every 6 weeks (Q6W) | Intervention Type: OTHER; Name: Sham Comparator; Assigned to Arm(s): Sham Comparator

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Brief Summary: This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).


Options:
A: Arm Label: Lampalizumab once in every 4 weeks (Q4W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Lampalizumab once in every 6 weeks (Q6W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Sham Comparator; Type: SHAM_COMPARATOR; Interventions: Other: Sham Comparator | Intervention Type: DRUG; Name: Lampalizumab; Assigned to Arm(s): Lampalizumab once in every 4 weeks (Q4W), Lampalizumab once in every 6 weeks (Q6W) | Intervention Type: OTHER; Name: Sham Comparator; Assigned to Arm(s): Sham Comparator
B: Arm Label: Lampalizumab Once in Every 4 Weeks (Q4W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Lampalizumab Once in Every 6 Weeks (Q6W); Type: EXPERIMENTAL; Interventions: Drug: Lampalizumab | Arm Label: Sham Comparator; Type: SHAM_COMPARATOR; Interventions: Other: Sham | Intervention Type: DRUG; Name: Lampalizumab; Assigned to Arm(s): Lampalizumab Once in Every 4 Weeks (Q4W), Lampalizumab Once in Every 6 Weeks (Q6W) | Intervention Type: OTHER; Name: Sham; Assigned to Arm(s): Sham Comparator
C: Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Arm Label: Eculizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eculizumab | Intervention Type: DRUG; Name: Eculizumab; Assigned to Arm(s): Eculizumab | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline
D: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis - a Randomized, Double-blind, Placebo-controlled, Prospective Study
Brief Summary: To evaluate the efficacy and safety of intravesical instillation of Lipotoxin for the treatment of IC/BPS


Options:
A: Arm Label: Group A: Liposome encapsulated BoNT-A; Type: EXPERIMENTAL; Interventions: Drug: Liposome encapsulated BoNT-A | Arm Label: Group B: BoNT-A 200 U in Normal saline; Type: EXPERIMENTAL; Interventions: Drug: BOTOX 200U in normal saline | Arm Label: Group C: Normal saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Liposome encapsulated BoNT-A; Assigned to Arm(s): Group A: Liposome encapsulated BoNT-A | Intervention Type: DRUG; Name: BOTOX 200U in normal saline; Assigned to Arm(s): Group B: BoNT-A 200 U in Normal saline | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Group C: Normal saline
B: Arm Label: Manual therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Manual therapy | Arm Label: Dry needling & manual therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Manual therapy, Procedure: Trigger point dry needling | Intervention Type: PROCEDURE; Name: Manual therapy; Assigned to Arm(s): Dry needling & manual therapy, Manual therapy | Intervention Type: PROCEDURE; Name: Trigger point dry needling; Assigned to Arm(s): Dry needling & manual therapy
C: Arm Label: Usual physiotherapy treatment group; Type: ACTIVE_COMPARATOR; Interventions: Other: Routine physiotherapy control | Arm Label: Therapeutic Wand group; Type: EXPERIMENTAL; Interventions: Device: Therapeutic Wand | Intervention Type: DEVICE; Name: Therapeutic Wand; Assigned to Arm(s): Therapeutic Wand group | Intervention Type: OTHER; Name: Routine physiotherapy control; Assigned to Arm(s): Usual physiotherapy treatment group
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: PF-04383119 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: PF-04383119; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Computer-aided Interlimb Force Coupling Training on Paretic Hand and Arm Motor Control Following Chronic Stroke
Brief Summary: The investigators hypothesized that bilateral handgrip force training would result in significant improvements in paretic hand, arm movements and daily functional performances. In order to investigate whether the improvement of paretic hand could facilitate the motor recovery of paretic arm and functional performances, the investigators also hypothesized that motor recovery and functional performances improvements of paretic arm and hand have strongly correlation.


Options:
A: Arm Label: Education & training consultation; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Bilateral movement training | Arm Label: Bilateral movement training; Type: EXPERIMENTAL; Interventions: Procedure: Bilateral movement training | Intervention Type: PROCEDURE; Name: Bilateral movement training; Assigned to Arm(s): Bilateral movement training, Education & training consultation
B: Arm Label: Virtual Reality Therapy; Type: EXPERIMENTAL; Interventions: Other: Virtual Reality | Arm Label: Traditional Therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional Therapy | Intervention Type: OTHER; Name: Virtual Reality; Assigned to Arm(s): Virtual Reality Therapy | Intervention Type: OTHER; Name: Traditional Therapy; Assigned to Arm(s): Traditional Therapy
C: Arm Label: E-glove system; Type: EXPERIMENTAL; Interventions: Device: E-glove system | Arm Label: Conventional occupational therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional occupational therapy | Intervention Type: DEVICE; Name: E-glove system; Assigned to Arm(s): E-glove system | Intervention Type: PROCEDURE; Name: Conventional occupational therapy; Assigned to Arm(s): Conventional occupational therapy
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: LapSimGyn training until expert proficiency level is reached | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional clinical education | Intervention Type: BEHAVIORAL; Name: LapSimGyn training until expert proficiency level is reached; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Traditional clinical education; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Computer-aided Interlimb Force Coupling Training on Paretic Hand and Arm Motor Control Following Chronic Stroke
Brief Summary: The investigators hypothesized that bilateral handgrip force training would result in significant improvements in paretic hand, arm movements and daily functional performances. In order to investigate whether the improvement of paretic hand could facilitate the motor recovery of paretic arm and functional performances, the investigators also hypothesized that motor recovery and functional performances improvements of paretic arm and hand have strongly correlation.


Options:
A: Arm Label: Education & training consultation; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Bilateral movement training | Arm Label: Bilateral movement training; Type: EXPERIMENTAL; Interventions: Procedure: Bilateral movement training | Intervention Type: PROCEDURE; Name: Bilateral movement training; Assigned to Arm(s): Bilateral movement training, Education & training consultation
B: Arm Label: Long term follow up program; Type: EXPERIMENTAL; Interventions: Behavioral: Long term follow up by a coordinating physiotherapist | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Long term follow up by a coordinating physiotherapist; Assigned to Arm(s): Long term follow up program | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
C: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard care | Arm Label: Standard Care + VEM; Type: EXPERIMENTAL; Interventions: Other: Standard Care + VEM | Intervention Type: OTHER; Name: Standard Care + VEM; Assigned to Arm(s): Standard Care + VEM | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard Care
D: Intervention Type: BEHAVIORAL; Name: Conventional UK Physical therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Increased intensity of UK conventional physical therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: UK conventional physical therapy plus functional strength training; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Prosthesis Choice in Older Patients With a Dislocated Femoral Neck Fracture of the Hip
Brief Summary: The purpose of this study is to evaluate whether an uncemented hip prosthesis is as safe as an cemented hip prosthesis for patients undergoing total hip arthroplasty surgery following a displaced femoral neck fracture.


Options:
A: Arm Label: Gamma nail, fracture stabilization, better walking; Type: ACTIVE_COMPARATOR; Interventions: Device: gamma nail stryker | Intervention Type: DEVICE; Name: gamma nail stryker; Assigned to Arm(s): Gamma nail, fracture stabilization, better walking
B: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Device: Cemented hemiarthroplasty | Arm Label: Treatment group; Type: ACTIVE_COMPARATOR; Interventions: Device: Cemented total hip arthroplasty | Intervention Type: DEVICE; Name: Cemented total hip arthroplasty; Assigned to Arm(s): Treatment group | Intervention Type: DEVICE; Name: Cemented hemiarthroplasty; Assigned to Arm(s): Control group
C: Arm Label: Cemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cemented femoral stem | Arm Label: Uncemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Uncemented femoral stem; Assigned to Arm(s): Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Cemented femoral stem; Assigned to Arm(s): Cemented femoral stem
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Total hip arthroplasty | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Hemi-arthroplasty | Intervention Type: DEVICE; Name: Total hip arthroplasty; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Hemi-arthroplasty; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Prosthesis Choice in Older Patients With a Dislocated Femoral Neck Fracture of the Hip
Brief Summary: The purpose of this study is to evaluate whether an uncemented hip prosthesis is as safe as an cemented hip prosthesis for patients undergoing total hip arthroplasty surgery following a displaced femoral neck fracture.


Options:
A: Arm Label: Single Sliding Hip Screw; Type: EXPERIMENTAL; Interventions: Device: Open reduction internal fixation (ORIF) with single sliding hip screw | Arm Label: Multiple Cancellous Screws; Type: EXPERIMENTAL; Interventions: Device: ORIF with multiple cancellous screws | Intervention Type: DEVICE; Name: Open reduction internal fixation (ORIF) with single sliding hip screw; Assigned to Arm(s): Single Sliding Hip Screw | Intervention Type: DEVICE; Name: ORIF with multiple cancellous screws; Assigned to Arm(s): Multiple Cancellous Screws
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Dual mobility cup | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard cup | Intervention Type: DEVICE; Name: Dual mobility cup; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: Standard cup; Assigned to Arm(s): Control
C: Arm Label: Conservative Treatment for Impacted Femoral Neck Fracture; Type: EXPERIMENTAL; Interventions: Procedure: Surgical Treatment for Impacted Femoral Neck Fracture | Intervention Type: PROCEDURE; Name: Surgical Treatment for Impacted Femoral Neck Fracture; Assigned to Arm(s): Conservative Treatment for Impacted Femoral Neck Fracture
D: Arm Label: Cemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cemented femoral stem | Arm Label: Uncemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Uncemented femoral stem; Assigned to Arm(s): Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Cemented femoral stem; Assigned to Arm(s): Cemented femoral stem

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan
Brief Summary: The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.


Options:
A: Intervention Type: DRUG; Name: duloxetine HCL; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: milnacipran hydrochloride; Assigned to Arm(s): N/A
C: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: duloxetine hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: duloxetine hydrochloride; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan
Brief Summary: The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.


Options:
A: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
C: Arm Label: Duloxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Duloxetine | Arm Label: Pregabalin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pregabalin | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin
D: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sugar pill | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Sugar pill; Assigned to Arm(s): Sugar pill

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laparoscopic Versus Open Gastrectomy for Gastric Cancer, a Multicenter Prospectively Randomized Controlled Trial (LOGICA-trial)
Brief Summary: This is the first randomized controlled trial comparing laparoscopic and open gastrectomy for resectable gastric cancer in a Western population. The hypothesis is that laparoscopic gastrectomy will result in a lower post-operative burden by means of shorter post-operative hospital stay. Secondarily that laparoscopic gastrectomy is hypothesized to be associated with lower post-operative morbidity and readmissions, higher cost-effectiveness, and better post-operative quality of life, with similar mortality and oncologic outcomes, compared to open gastrectomy. The study starts on 1 December 2014. Inclusion and follow-up will take three and five years respectively. Short-term results will be analyzed and published after discharge of the last randomized patient.


Options:
A: Arm Label: open distal gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: open distal gastrectomy | Arm Label: laparoscopy assisted distal gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: laparoscopy assisted distal gastrectomy | Intervention Type: PROCEDURE; Name: laparoscopy assisted distal gastrectomy; Assigned to Arm(s): laparoscopy assisted distal gastrectomy | Intervention Type: PROCEDURE; Name: open distal gastrectomy; Assigned to Arm(s): open distal gastrectomy
B: Arm Label: Laparoscopy assisted distal gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: laparoscopy assisted distal gastrectomy | Arm Label: Open Distal Gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open distal gastrectomy | Intervention Type: PROCEDURE; Name: laparoscopy assisted distal gastrectomy; Assigned to Arm(s): Laparoscopy assisted distal gastrectomy | Intervention Type: PROCEDURE; Name: Open distal gastrectomy; Assigned to Arm(s): Open Distal Gastrectomy
C: Arm Label: Open Gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Gastrectomy | Arm Label: Laparoscopic Gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic Gastrectomy | Intervention Type: PROCEDURE; Name: Open Gastrectomy; Assigned to Arm(s): Open Gastrectomy | Intervention Type: PROCEDURE; Name: Laparoscopic Gastrectomy; Assigned to Arm(s): Laparoscopic Gastrectomy
D: Arm Label: Minimally-invasive Gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: Minimally-invasive gastrectomy | Arm Label: Open Gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Gastrectomy | Intervention Type: PROCEDURE; Name: Minimally-invasive gastrectomy; Assigned to Arm(s): Minimally-invasive Gastrectomy | Intervention Type: PROCEDURE; Name: Open Gastrectomy; Assigned to Arm(s): Open Gastrectomy

Answer: C